FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022934067> ?p ?o ?g. }

• W2022934067 endingPage "801" @default.
• W2022934067 startingPage "789" @default.
• W2022934067 abstract "Several mitogens such as vascular endothelial growth factor (VEGF) have been implicated in mammalian vascular proliferation and repair. However, the molecular mediators of human blood-nerve barrier (BNB) development and specialization are unknown. Primary human endoneurial endothelial cells (pHEndECs) were expanded in vitro and specific mitogen receptors detected by western blot. pHEndECs were cultured with basal medium containing different mitogen concentrations with or without heparin. Non-radioactive cell proliferation, Matrigel(™)-induced angiogenesis and sterile micropipette injury wound healing assays were performed. Proliferation rates, number and total length of induced microvessels, and rate of endothelial cell monolayer wound healing were determined and compared to basal conditions. VEGF-A165 in the presence of heparin, was the most potent inducer of pHEndEC proliferation, angiogenesis, and wound healing in vitro. 1.31 nM VEGF-A165 induced ~110 % increase in cell proliferation relative to basal conditions (∼51 % without heparin). 2.62 pM VEGF-A165 induced a three-fold increase in mean number of microvessels and 3.9-fold increase in total capillary length/field relative to basal conditions. In addition, 0.26 nM VEGF-A165 induced ∼1.3-fold increased average rate of endothelial wound healing 4-18 h after endothelial monolayer injury, mediated by increased cell migration. VEGF-A165 was the only mitogen capable of complete wound closure, occurring within 30 h following injury via increased cell proliferation. This study demonstrates that VEGF-A165, in the presence of heparin, is a potent inducer of pHEndEC proliferation, angiogenesis, and wound healing in vitro. VEGF-A165 may be an important mitogen necessary for human BNB development and recovery in response to peripheral nerve injury." @default.
• W2022934067 created "2016-06-24" @default.
• W2022934067 creator A5049397601 @default.
• W2022934067 creator A5062121723 @default.
• W2022934067 creator A5087448771 @default.
• W2022934067 date "2013-05-26" @default.
• W2022934067 modified "2023-10-14" @default.
• W2022934067 title "VEGF-A165 Potently Induces Human Blood–Nerve Barrier Endothelial Cell Proliferation, Angiogenesis, and Wound Healing In Vitro" @default.
• W2022934067 cites W1486528432 @default.
• W2022934067 cites W1548786914 @default.
• W2022934067 cites W1557680767 @default.
• W2022934067 cites W1905392838 @default.
• W2022934067 cites W1966389744 @default.
• W2022934067 cites W1967974734 @default.
• W2022934067 cites W1979432465 @default.
• W2022934067 cites W1980661152 @default.
• W2022934067 cites W1980791390 @default.
• W2022934067 cites W1983442818 @default.
• W2022934067 cites W1986201902 @default.
• W2022934067 cites W1988384513 @default.
• W2022934067 cites W1989769985 @default.
• W2022934067 cites W1990331345 @default.
• W2022934067 cites W1997575011 @default.
• W2022934067 cites W2001414744 @default.
• W2022934067 cites W2012018288 @default.
• W2022934067 cites W2012705499 @default.
• W2022934067 cites W2016036581 @default.
• W2022934067 cites W2018827318 @default.
• W2022934067 cites W2027685865 @default.
• W2022934067 cites W2030282028 @default.
• W2022934067 cites W2032678192 @default.
• W2022934067 cites W2036173770 @default.
• W2022934067 cites W2039836896 @default.
• W2022934067 cites W2040423204 @default.
• W2022934067 cites W2040854254 @default.
• W2022934067 cites W2043859318 @default.
• W2022934067 cites W2047841272 @default.
• W2022934067 cites W2047876147 @default.
• W2022934067 cites W2048210677 @default.
• W2022934067 cites W2050644791 @default.
• W2022934067 cites W2058595603 @default.
• W2022934067 cites W2059368790 @default.
• W2022934067 cites W2063395736 @default.
• W2022934067 cites W2064634626 @default.
• W2022934067 cites W2068883959 @default.
• W2022934067 cites W2069524101 @default.
• W2022934067 cites W2071079524 @default.
• W2022934067 cites W2071749936 @default.
• W2022934067 cites W2075026340 @default.
• W2022934067 cites W2075175167 @default.
• W2022934067 cites W2076503648 @default.
• W2022934067 cites W2078964196 @default.
• W2022934067 cites W2080634225 @default.
• W2022934067 cites W2081734743 @default.
• W2022934067 cites W2087741637 @default.
• W2022934067 cites W2088504232 @default.
• W2022934067 cites W2094496747 @default.
• W2022934067 cites W2095342969 @default.
• W2022934067 cites W2100432653 @default.
• W2022934067 cites W2101929583 @default.
• W2022934067 cites W2106389977 @default.
• W2022934067 cites W2120298603 @default.
• W2022934067 cites W2133498810 @default.
• W2022934067 cites W2144283177 @default.
• W2022934067 cites W2144707486 @default.
• W2022934067 cites W2149789317 @default.
• W2022934067 cites W2152877944 @default.
• W2022934067 cites W2223269519 @default.
• W2022934067 cites W2912349604 @default.
• W2022934067 cites W2953375613 @default.
• W2022934067 cites W4254868516 @default.
• W2022934067 doi "https://doi.org/10.1007/s10571-013-9946-3" @default.
• W2022934067 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3723762" @default.
• W2022934067 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23712256" @default.
• W2022934067 hasPublicationYear "2013" @default.
• W2022934067 type Work @default.
• W2022934067 sameAs 2022934067 @default.
• W2022934067 citedByCount "18" @default.
• W2022934067 countsByYear W20229340672014 @default.
• W2022934067 countsByYear W20229340672015 @default.
• W2022934067 countsByYear W20229340672016 @default.
• W2022934067 countsByYear W20229340672017 @default.
• W2022934067 countsByYear W20229340672018 @default.
• W2022934067 countsByYear W20229340672019 @default.
• W2022934067 countsByYear W20229340672020 @default.
• W2022934067 countsByYear W20229340672021 @default.
• W2022934067 countsByYear W20229340672023 @default.
• W2022934067 crossrefType "journal-article" @default.
• W2022934067 hasAuthorship W2022934067A5049397601 @default.
• W2022934067 hasAuthorship W2022934067A5062121723 @default.
• W2022934067 hasAuthorship W2022934067A5087448771 @default.
• W2022934067 hasBestOaLocation W20229340672 @default.
• W2022934067 hasConcept C123012128 @default.
• W2022934067 hasConcept C146285616 @default.
• W2022934067 hasConcept C167734588 @default.
• W2022934067 hasConcept C185592680 @default.
• W2022934067 hasConcept C202751555 @default.
• W2022934067 hasConcept C203014093 @default.

• next